These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2913725)
1. [Serial determination of anthracycline poisoning in children]. Stein JI; Langevin A; Benson LN; Souza MD; Wilson G; Chan H Wien Klin Wochenschr; 1989 Jan; 101(1):45-8. PubMed ID: 2913725 [TBL] [Abstract][Full Text] [Related]
2. [Clinical usefulness of quantitative two-dimensional echocardiographic analysis of segmental kinesis of the left ventricle in monitoring of patients with neoplasms treated with anthracyclines]. Pisacane C; Iarussi D; Buono S; Gualtieri S; Coppolino P; Iacono A G Ital Cardiol; 1991 Dec; 21(12):1259-67. PubMed ID: 1818000 [TBL] [Abstract][Full Text] [Related]
3. Time- and dose-dependent changes in ejection fraction determined by radionuclide angiography after anthracycline therapy. Singer JW; Narahara KA; Ritchie JL; Hamilton GW; Kennedy JW Cancer Treat Rep; 1978 Jun; 62(6):945-8. PubMed ID: 667873 [TBL] [Abstract][Full Text] [Related]
4. Exposure to anthracyclines during childhood causes cardiac injury. Lipshultz SE Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284 [TBL] [Abstract][Full Text] [Related]
5. Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer. Tan CT; Hancock C; Steinherz P; Bacha DM; Steinherz L; Luks E; Winick N; Meyers P; Mondora A; Dantis E Cancer Res; 1987 Jun; 47(11):2990-5. PubMed ID: 3471321 [TBL] [Abstract][Full Text] [Related]
6. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer. Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034 [TBL] [Abstract][Full Text] [Related]
7. Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Fujimaki K; Maruta A; Yoshida M; Sakai R; Tanabe J; Koharazawa H; Kodama F; Asahina S; Minamizawa M; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y Bone Marrow Transplant; 2001 Feb; 27(3):307-10. PubMed ID: 11277179 [TBL] [Abstract][Full Text] [Related]
8. Anthracycline cardiomyopathy monitored by morphologic changes. Billingham ME; Mason JW; Bristow MR; Daniels JR Cancer Treat Rep; 1978 Jun; 62(6):865-72. PubMed ID: 667860 [TBL] [Abstract][Full Text] [Related]
9. Use of endomyocardial biopsy to assess anthracycline-induced cardiotoxicity. Jones RL; Miles DW Lancet Oncol; 2005 Feb; 6(2):67. PubMed ID: 15683815 [No Abstract] [Full Text] [Related]
10. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia. Gulen H; Kazanci E; Mese T; Uzunkaya D; Erbay A; Tavli V; Vergin C Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560 [TBL] [Abstract][Full Text] [Related]
11. [Cardiotoxicity of anthracyclines in children. Contribution of anthracyclines in pediatric oncology]. Biron P; Philip T; Bouffet E; Favrot MC; Pinkerton R; Brunat-Mentigny M Pathol Biol (Paris); 1987 Jan; 35(1):97-101. PubMed ID: 3550619 [TBL] [Abstract][Full Text] [Related]
13. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer. Giordano SH; Booser DJ; Murray JL; Ibrahim NK; Rahman ZU; Valero V; Theriault RL; Rosales MF; Rivera E; Frye D; Ewer M; Ordonez NG; Buzdar AU; Hortobagyi GN Clin Cancer Res; 2002 Nov; 8(11):3360-8. PubMed ID: 12429622 [TBL] [Abstract][Full Text] [Related]
14. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Bristow MR; Billingham ME; Mason JW; Daniels JR Cancer Treat Rep; 1978 Jun; 62(6):873-9. PubMed ID: 667861 [TBL] [Abstract][Full Text] [Related]
16. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy]. Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153 [TBL] [Abstract][Full Text] [Related]
17. Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children. Lewis AB; Crouse VL; Evans W; Takahashi M; Siegel SE Pediatrics; 1981 Jul; 68(1):67-72. PubMed ID: 6941210 [TBL] [Abstract][Full Text] [Related]
18. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG). Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710 [TBL] [Abstract][Full Text] [Related]
19. Reducing the cardiotoxicity of the anthracyclines. Carlson RW Oncology (Williston Park); 1992 Jun; 6(6):95-100, 104, 107, discussion 107-8. PubMed ID: 1535212 [TBL] [Abstract][Full Text] [Related]
20. [Echocardiography studies for detection of cardiotoxic side effects of anthracycline therapy in childhood]. Richter R; Grumpelt U; Mittler U; Kluba U Monatsschr Kinderheilkd; 1990 Dec; 138(12):823-7. PubMed ID: 1965011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]